company background image
ACL

Australian Clinical Labs ASX:ACL Stock Report

Last Price

AU$3.44

Market Cap

AU$690.8m

7D

-0.6%

1Y

-18.5%

Updated

27 Nov, 2022

Data

Company Financials +

Australian Clinical Labs Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Australian Clinical Labs
Historical stock prices
Current Share PriceAU$3.44
52 Week HighAU$6.39
52 Week LowAU$3.12
Beta0
1 Month Change3.93%
3 Month Change-17.70%
1 Year Change-18.48%
3 Year Changen/a
5 Year Changen/a
Change since IPO0.59%

Recent News & Updates

Recent updates

Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Aug 14
Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Feb 25
Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

Dec 22
New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

Dec 21
The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

Sep 01
The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

Shareholder Returns

ACLAU HealthcareAU Market
7D-0.6%1.7%1.2%
1Y-18.5%-15.3%-2.9%

Return vs Industry: ACL underperformed the Australian Healthcare industry which returned -15.3% over the past year.

Return vs Market: ACL underperformed the Australian Market which returned -2.9% over the past year.

Price Volatility

Is ACL's price volatile compared to industry and market?
ACL volatility
ACL Average Weekly Movement5.5%
Healthcare Industry Average Movement5.3%
Market Average Movement9.0%
10% most volatile stocks in AU Market16.1%
10% least volatile stocks in AU Market4.2%

Stable Share Price: ACL is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: ACL's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20205,400Melinda McGrathhttps://www.clinicallabs.com.au

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals.

Australian Clinical Labs Limited Fundamentals Summary

How do Australian Clinical Labs's earnings and revenue compare to its market cap?
ACL fundamental statistics
Market CapAU$690.79m
Earnings (TTM)AU$178.24m
Revenue (TTM)AU$995.60m

3.9x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ACL income statement (TTM)
RevenueAU$995.60m
Cost of RevenueAU$232.98m
Gross ProfitAU$762.63m
Other ExpensesAU$584.38m
EarningsAU$178.24m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Feb 23, 2023

Earnings per share (EPS)0.89
Gross Margin76.60%
Net Profit Margin17.90%
Debt/Equity Ratio0%

How did ACL perform over the long term?

See historical performance and comparison

Dividends

15.4%

Current Dividend Yield

60%

Payout Ratio